NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, January 3rd. Stockholders of record on Friday, January 25th will be paid a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 annualized dividend and a dividend yield of 2.86%. The ex-dividend date of this dividend is Thursday, January 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) posted its earnings results on Wednesday, August, 8th. The pharmacy operator reported $1.69 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.61 by $0.08. The pharmacy operator had revenue of $46.71 billion for the quarter, compared to the consensus estimate of $46.34 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The firm's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.33 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 20th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

15 Wall Street analysts have issued 1 year target prices for CVS Health's shares. Their forecasts range from $75.00 to $104.00. On average, they anticipate CVS Health's stock price to reach $91.7857 in the next year. This suggests a possible upside of 31.3% from the stock's current price. View Analyst Price Targets for CVS Health.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media stories about CVS stock have been trending somewhat positive this week, InfoTrie reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CVS Health earned a news impact score of 0.9 on InfoTrie's scale. They also gave media headlines about the pharmacy operator a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

CVS Health saw a increase in short interest in January. As of January 31st, there was short interest totalling 14,420,741 shares, an increase of 35.1% from the January 15th total of 10,671,652 shares. Based on an average trading volume of 9,924,659 shares, the days-to-cover ratio is presently 1.5 days. Currently, 1.1% of the shares of the stock are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.12%), Oregon Public Employees Retirement Fund (2.46%), Barrow Hanley Mewhinney & Strauss LLC (1.88%), Northern Trust Corp (1.76%), Geode Capital Management LLC (1.62%) and Bank of New York Mellon Corp (1.43%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., First American Bank, Parnassus Investments CA, CI Investments Inc., Harris Associates L P, Kiltearn Partners LLP, DNB Asset Management AS and State Treasurer State of Michigan. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Geode Capital Management LLC, Epoch Investment Partners Inc., Northern Trust Corp, Dimensional Fund Advisors LP, Diamond Hill Capital Management Inc. and Bank of New York Mellon Corp. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $69.88.

CVS Health has a market capitalization of $71.19 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 160,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]